Pharmaceutical Technology

MAY 15, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Antibody 130

Antibody DNA Development Vaccination 130

XTalks

OCTOBER 12, 2022

However, the role of MRI in new drug clinical trials can involve diagnosis of lesions and determination of their severity, early identification of therapeutic responders to drug treatment and treatment monitoring and follow-up. For most of this time, MRI mainly was used for qualitative interpretation and simple structural measurements.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

Rethinking Clinical Trials

MARCH 21, 2023

In a model for systematic symptom monitoring, a patient might report symptoms electronically in real-time via e-reports or e-alerts so the care team can respond proactively and have data to review at the next visit. The PRO-TECT Cancer Symptom Study was a cluster randomized trial at 52 U.S.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Delveinsight

DECEMBER 3, 2020

The FDA nods for the Elecsys Anti-SARS-CoV-2 S quantitative antibody test that runs on Roche’s cobas e analyzers, follows its September launch in Europe after receiving a CE mark. Zimmer Biomet buys chest surgery toolmaker A&E Medical. of the time and negative results 99.98% of the time, as per Roche.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

Drug Discovery World

NOVEMBER 9, 2023

Kielczewska will present: ‘Discovery of antibody-based therapeutics to challenging targets: Platform considerations’. Simone Oostindie, PhD, Director, Research and Discovery, Gyes, on: ‘Avidity engineering: A next frontier in the development of differentiating antibody therapeutics’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

pharmaphorum

FEBRUARY 26, 2021

Between 1976 and 1989, James E. Under his leadership, the company entered new therapeutic areas. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. Acquisitions post-Janssen. Burke was chairman and CEO of J&J. billion the following February.

Sales 126

Sales Production Pharma Companies Marketing 126